The drug database for acute porphyria

Select language: English Norwegian Swedish French

By using this website, we consider that you accept the following:



Disclaimer, Terms of Use, and Copyright Notice for the Drug Database for Acute Porphyria Disclaimer: The Drug Database for Acute Porphyria is a property of The Norwegian Porphyria Centre (NAPOS). The information provided in this database is intended for use by healthcare professionals. While it may be of interest to patients, decisions regarding drug use in acute porphyria should always be made in consultation with healthcare professionals. In cases of uncertainty, additional advice should be sought. The database comprises expert assessments of the potential of drugs to provoke porphyria attacks in patients with acute hepatic porphyria, including Acute Intermittent Porphyria (AIP), Variegate Porphyria (VP), Hereditary Coproporphyria (HCP), and ALA Dehydratase Deficiency Porphyria (ADP). It offers guidance based on a thorough evaluation of international clinical experience, published case reports, and theoretical considerations. The information presented in this database, which involves some degree of uncertainty, serves as guidance to healthcare professionals. The Norwegian Porphyria Centre (NAPOS) accepts no responsibility for any errors, differences of opinion, or adverse consequences arising from the use of information published on this website. Terms of Use: 1. New information may be periodically added to the database, and existing data may be subject to change. 2. All information on this website is published in good faith by The Norwegian Porphyria Centre (NAPOS) for general informational purposes only. It is subject to change without notice. 3. NAPOS does not make any warranties or guarantees about the completeness, reliability, and accuracy of the information. Users acknowledge that any action taken based on the information found on this website is strictly at their own risk. 4. NAPOS will not be liable for any losses and/or damages in connection with the use of the The Drug Database for Acute Porphyria. 5. While efforts are made to keep the website operational, NAPOS takes no responsibility for and will not be liable for any temporary unavailability due to technical issues beyond our control. 6. Limitations on the use of data from this website are outlined in the Copyright section. 7. If using data from this website, proper referencing is required. Refer to: The Drug Database for Acute Porphyria. The Norwegian Porphyria Centre (NAPOS). https://www.drugs-porphyria.org/ [time of access]. 8. By using this website, users consent to the disclaimer and agree to its terms of use. Copyright Notice: This website and its content are the copyright of The Norwegian Porphyria Centre (NAPOS). All rights reserved. 1. Distribution or commercial exploitation of the content is prohibited without express written permission from NAPOS (contact: drugs.porphyria@helse-bergen.no) 2. Users are permitted to print or download extracts for personal and non-commercial use only. 3. When presenting or referring to the content, users must acknowledge the website as the source of the material. 4. Transmission or storage of the content on any other website or electronic retrieval system is strictly prohibited.